Cargando…
Current Challenges in Prostate Cancer Management and the Rationale behind Targeted Focal Therapy
Among men, prostate cancer has a high prevalence, with relatively lower cancer-specific mortality risk compared to lung and colon cancer. Prostate-specific antigen (PSA) screening has increased prostate cancer awareness since its implementation as a screening tool almost 25 years ago, but, due to th...
Autores principales: | Barqawi, Al B., Krughoff, Kevin J., Eid, Khadijah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3357537/ https://www.ncbi.nlm.nih.gov/pubmed/22649447 http://dx.doi.org/10.1155/2012/862639 |
Ejemplares similares
-
The Role of Targeted Focal Therapy in the Management of Low-Risk Prostate Cancer: Update on Current Challenges
por: Smith, Daniel W., et al.
Publicado: (2012) -
The Accuracy of Prostate Cancer Localization Diagnosed on Transrectal Ultrasound-Guided Biopsy Compared to 3-Dimensional Transperineal Approach
por: Krughoff, Kevin, et al.
Publicado: (2013) -
Focal Therapy for Prostate Cancer: Rationale and Treatment Opportunities
por: Kasivisvanathan, V., et al.
Publicado: (2013) -
The Prognostic Value of Previous Irradiation on Survival of Bladder Cancer Patients
por: Krughoff, Kevin, et al.
Publicado: (2015) -
Focal therapy in prostate cancer: the current situation
por: Jácome-Pita, FX, et al.
Publicado: (2014)